Position in CGC
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$38,064
+$60 QoQ
Shares Held
40,068
+0.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#44
of 212 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Genesee Capital Advisors, LLC holds $1,817,267 across 3 Drug Manufacturers - Specialty & Generic names. CGC ranks #3 (2.1% of the industry book) .
All Filings in CGC
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,064 | 40,068 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $38,004 | 40,047 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $45,653 | 40,047 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $58,468 | 40,047 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $18,357 | 15,047 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $13,692 | 15,047 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $41,228 | 15,047 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $72,526 | 15,047 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $97,053 | 15,047 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $112,595 | 13,047 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $51,340 | 10,047 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $39,518 | 50,470 | Shares | Sole | 2023-10-25 | |
| No filing history on record for this holder in this stock. | ||||||